Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV, Combination Therapy”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Not applicableStudy completedNCT01637233
What this trial is testing

MARCH Central Nervous System Substudy

Who this might be right for
HIV-1 Infection
Kirby Institute 28
Testing effectiveness (Phase 2)Study completedNCT01199939
What this trial is testing

The Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)
Tibotec, Inc 54
Testing effectiveness (Phase 2)Study completedNCT00002357
What this trial is testing

The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms

Who this might be right for
HIV Infections
Hoechst Marion Roussel 144
Not applicableStudy completedNCT00000636
What this trial is testing

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 2,000
Post-approval studies (Phase 4)Study completedNCT04388904
What this trial is testing

Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)

Who this might be right for
HIV-1-infection
The Crofoot Research Center, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Testing effectiveness (Phase 2)Study completedNCT00002412
What this trial is testing

MKC-442 in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Early research (Phase 1)Study completedNCT00000986
What this trial is testing

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT00056641
What this trial is testing

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 328
Post-approval studies (Phase 4)UnknownNCT00011895
What this trial is testing

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
GlaxoSmithKline 400
Not applicableUnknownNCT00974519
What this trial is testing

The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients

Who this might be right for
Acquired Immune Deficiency Syndrome VirusHIV Infections
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 180
Not applicableUnknownNCT06019273
What this trial is testing

Impacts of Different ART Regimens on Lipid Metabolism in People Living With HIV

Who this might be right for
HIV InfectionCombined Antiretroviral Therapy
First Affiliated Hospital of Zhejiang University 180
Testing effectiveness (Phase 2)Study completedNCT00000641
What this trial is testing

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT00006441
What this trial is testing

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 398
Not applicableStudy completedNCT00016783
What this trial is testing

Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 39
Testing effectiveness (Phase 2)Ended earlyNCT01026727
What this trial is testing

Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy

Who this might be right for
HIV Infections
Myrexis Inc. 2
Testing effectiveness (Phase 2)Study completedNCT00000912
What this trial is testing

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 475
Post-approval studies (Phase 4)Temporarily pausedNCT00143728
What this trial is testing

3TC or No 3TC for HIV With 3TC Resistance

Who this might be right for
HIV Infections
University of British Columbia 152
Large-scale testing (Phase 3)Study completedNCT00381303
What this trial is testing

GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.

Who this might be right for
HIVInfectious
Tibotec, Inc 429
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation